President Trump has approved Medicare coverage for a costly bandage produced by Extremity Care, a company that has donated millions to his campaign. The decision comes after the company’s supporters provided talking points for the president, raising questions about potential conflicts of interest. The administration has also delayed a regulatory change that could have affected the bandage company and similar firms, citing the need for further review.
The head of Extremity Care, who is a major donor to Trump’s campaign, recently attended a candlelit dinner at Mar-a-Lago. During the event, he voiced concerns about the regulatory challenges facing his business, highlighting the potential impact on the company’s operations. This meeting underscores the complex relationship between corporate interests and political influence, particularly within the healthcare sector.